NCT01362153View on ClinicalTrials.gov

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

December 26, 2007

Primary Completion Date

February 27, 2009

Study Completion Date

February 27, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Golimumab

SC injection of 100 mg every 4 weeks through Week 20

DRUG

Golimumab

IV infusions of 2 mg/kg golimumab on Days 1 and 85.

Trial Locations (9)

Unknown

Glendale

Aventura

Palm Harbor

Lexington

Baton Rouge

Worcester

Oklahoma City

Duncansville

Houston

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY